Zhuang medicine has a long history and a long history. Guangxi Phnom Penh leech has been a Zhuang medicine since ancient times, and the ancestors of the Zhuang people have recorded that it has protected the health and longevity of the Zhuang people for thousands of years, and has become an indispensable precious medicinal material for the life of the Zhuang people.
Zhong Yunbo, chairman of Guangxi Shennong Golden Leech Biopharmaceutical Group Co., Ltd
Leeches, commonly known as leeches, are traditional Chinese special medicinal aquatic bloodsucking link animals, growing and breeding in inland freshwater waters, with a total of 116 species. The Phnom Penh leech is named after a golden border on each side of the leech's body, and its medical name is the Phi bull leech, which belongs to the medical leech suborder Medical leech family.
Leeches mainly grow in rice fields and lakes, and the origin of rice culture is closely related to the growth environment of leeches, which is an important correlation that leeches can be found as strong medicine and applied to medical treatment, condensing the wisdom crystallization of ancient people. Guangxi is one of the few places in the country where Phnom Penh leech is suitable for birth, and the development of breeding conditions is unique, for this reason, Phnom Penh leech has become a characteristic medicinal animal resource in Guangxi, a rare and precious species.
Hirudin is a low-molecular active polypeptide extracted from the saliva and effective parts of blood-sucking leeches, which is a strong natural antithrombin substance found in the world, and has important and high development and application value for common high-incidence major diseases such as cardiovascular and cerebrovascular diseases. In 1884, British Dr. Haycraft discovered leech anticoagulant substances, and in 1904 British Jacoby named this anticoagulant as hirudin. Animal tests and clinical studies have shown that hirudin is a promising class of anticoagulant drugs that can be used to treat various thrombotic diseases.
Guangxi Phnom Penh leech artificial breeding began at the end of the last century and has now reached the effect of high density and high yield. In September 2021, the "Code of Practice for Leech Therapy of Zhuang Medicine" passed the expert review, which is the first Zhuang medical group standard in Guangxi proposed by Guangxi International Zhuang Medical Hospital, drafted together with Guangxi University of Chinese Medicine and other units, and approved by the Guangxi Standardization Association. The issuance and implementation of the standard is of great significance to standardize the operation of Zhuang medical leech therapy, carry forward and promote the traditional characteristics of Zhuang medicine leech therapy, and promote the development of Guangxi Zhuang medicine. Zhuangyi leech therapy is a method of using hungry live leeches to suck and treat the road network (acupuncture points/pain points) on the human body surface to achieve the purpose of treating diseases. At present, Guangxi Shennong Golden Leech Biopharmaceutical Group Co., Ltd. and Guangxi Kekang Technology Group Co., Ltd. have increased breeding and research efforts, Phnom Penh leech breeding technology and purification technology have been very mature, and opened up the complete hirudin industry chain of domestic enterprises from breeding, research and development, production, sales to service, and is the first enterprise in China to have patented technology for natural hirudin extraction and production and realize the large-scale production of natural hirudin (active peptide products). Certified by experts, Guangxi Phnom Penh leech hirudin is the leech variety with the highest medicinal active ingredient hirudin, dozens of times higher than other known varieties.
With breeding and scientific research achievements, the next step is to push hirudin to a new highland, to this end, we have widely listened to and solicited the professional opinions of domestic experts and scholars, and clarified the prospect plan for the company's development, that is, make good use of the national and autonomous region policies, integrate regional resources, give full play to location and platform advantages, and seize industrial opportunities, which is the focus of the development of Guangxi Phnom Penh leech hirudin industry.
On August 30, 2021, the General Office of the People's Government of Guangxi Zhuang Autonomous Region issued the Overall Plan of Fangchenggang International Medical Open Pilot Zone, focusing on international medical exchanges and cooperation, developing modern pharmaceutical industry, developing traditional medicine and food industries, developing medical and health services, and activating new momentum for opening up and development. As an important node city of the new land-sea corridor in the western part of the country, the main gateway of the China-ASEAN Free Trade Area, and the core city of the Guangxi Beibu Gulf Economic Zone, Fangchenggang occupies a particularly important position in the construction of the "Belt and Road". In other words, among these major initiatives, Guangxi Shennong Golden Leech Biopharmaceutical Group Co., Ltd. has encountered a golden opportunity for development.
Opportunities and challenges coexist, rainbows and wind and rain coexist. The east wind of the national and autonomous region policy is the biggest "time of day", the company's various clear and effective positioning is "favorable location", the team unites to achieve "people", how to gather the advantages of "time and place favorable people", expand and revitalize the strategic hirudin industry, and comprehensively promote the construction of a healthy China, which is the top priority of the current development of Guangxi Shennong Golden Leech Biopharmaceutical Group Co., Ltd.
We know that the success of an enterprise is not one or two accidental market successes or a little more share than competitors, but in the process of development, enterprises need to gradually accumulate the three advantages of "the right time and place" according to priorities, and finally be invincible in the market and competition, and maintain long-term stability is success.
To this end, Guangxi Shennong Golden Leech Biopharmaceutical Group Co., Ltd. rides on the east wind of the establishment of the international medical open experimental zone in Fangchenggang, Guangxi, and Guangxi Kekang Technology Group Co., Ltd., will build a natural hirudin biotechnology park in the Fangchenggang High-tech Industrial Development Zone, including leech breeding base, leech breeding base, research and development and pharmaceutical factory, with a total area of 1,000 mu and an estimated investment of RMB 1 billion. The park focuses on the development of medicines, medical devices and health foods, lays out a national food safety and nutrition innovation platform, and promotes international cooperation in the research and development and production of nutritional and health foods. The Science and Technology Park will implement the national medical and health industry development policy and industrial integration development strategy, strengthen the development of Guangxi Zhuang Pharmaceutical, promote the Fangchenggang International Medical Open Pilot Zone, and promote the coordinated development of production and service industries. The project is expected to make outstanding contributions to Fangchenggang City's optimization of industrial structure, innovation of industrial development model, acceleration of the transformation and upgrading of the pharmaceutical industry, and deepening inter-regional exchanges and cooperation between industries. After the completion and operation of the Science and Technology Park, it will drive the pharmaceutical and health industry in Fangchenggang City to achieve leapfrog development, promote residents' employment, help promote common prosperity, and achieve industrial upgrading and healthy and sustainable development. In addition, relying on the development and utilization of hirudin projects, the company will work closely with 300 hospitals within three years to establish 5,000 Zhuangyi leech live therapy medical clinics across the country, which is in combination with the natural hirudin biotechnology park, which is conducive to building a medical and health demonstration base that leads the treatment of cardiovascular and cerebrovascular diseases in the country and even the world, and benefits human health.
The company and Guangdong Nanyue Group Co., Ltd. jointly registered and established Macau Shennong Leech Biomedical Co., Ltd. in Macao to produce functional foods and take advantage of Macao's unique location to promote hirudin to the world.
We believe that by making good use of these advantages, Guangxi Phnom Penh leech hirudin will definitely win the first opportunity in this wave, and Guangxi Phnom Penh leech hirudin will also move to a new high ground and create more brilliant achievements.